ZFPM2 and hepatocellular carcinoma: Yan et al. reported that seven lncRNAs, including AC009005.2, RP11-363N22.3, RP11-932O9.10, RP11-572O6.1, RP11-190C22.8, RP11-388C12.8, and ZFPM2-AS1, were associated with OS of HCC patients, and the seven-lncRNA signature could also divide patients into the high-risk and low-risk groups with significantly different OS [13].